Incannex Healthcare (IXHL) Operating Income (2022 - 2026)
Incannex Healthcare's (IXHL) quarterly Operating Income came in at -$4.0 million in Q1 2026, up 19.09% year-over-year from -$3.4 million in Q1 2025, and up 42.13% quarter-over-quarter from -$7.0 million in Q4 2025.
Analysis
Incannex Healthcare (IXHL) Operating Income (2022 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Operating Income across 5 years of filings, most recently posting -$4.0 million for Q1 2026.
- In Q1 2026, Operating Income rose 19.09% year-over-year to -$4.0 million; the TTM figure through Mar 2026 stood at -$25.4 million (up 2.46% YoY), while the FY2025 annual figure was -$23.8 million, up 20.81% from the prior year.
- Operating Income came in at -$4.0 million for Q1 2026 at Incannex Healthcare, up from -$7.0 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$3.6 million in Q4 2022 to a low of -$9.7 million in Q2 2024.
- Average Operating Income over 5 years is -$5.9 million, with a median of -$5.6 million recorded in 2024.
- The largest YoY upside for Operating Income was 37.32% in 2024 against a maximum downside of 132.33% in 2024.
- Over 5 years, Operating Income stood at -$3.6 million in 2022, then sank by 119.37% to -$8.0 million in 2023, then surged by 37.32% to -$5.0 million in 2024, then tumbled by 39.79% to -$7.0 million in 2025, then surged by 42.13% to -$4.0 million in 2026.
- Per Business Quant data, the three most recent Operating Income figures were -$4.0 million in Q1 2026, -$7.0 million in Q4 2025, and -$6.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | 4.27 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | -505.13 Mn |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 697.90 Mn |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 330.80 Mn |
| 10 | Incannex Healthcare | 41.43 Mn | 41.43 Mn | - | -4.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -4.05 Mn |
| Dec 31, 2025 | -7.00 Mn |
| Sep 30, 2025 | -6.79 Mn |
| Jun 30, 2025 | -7.53 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Dec 31, 2024 | -5.00 Mn |
| Sep 30, 2024 | -6.25 Mn |
| Jun 30, 2024 | -9.74 Mn |
| Mar 31, 2024 | -7.42 Mn |
| Dec 31, 2023 | -7.98 Mn |
| Sep 30, 2023 | -4.89 Mn |
| Jun 30, 2023 | -4.19 Mn |
| Mar 31, 2023 | -3.65 Mn |
| Dec 31, 2022 | -3.64 Mn |